Global Drug Eluting Balloons (DEBs) Market Trajectory & Analytics to 2027: U.S. Market is Estimated at $119.8 Million, While China is Forecast to Grow at 23.4% CAGR – ResearchAndMarkets.com

Global Drug Eluting Balloons (DEBs) Market Trajectory & Analytics to 2027: U.S. Market is Estimated at $119.8 Million, While China is Forecast to Grow at 23.4% CAGR – ResearchAndMarkets.com




Global Drug Eluting Balloons (DEBs) Market Trajectory & Analytics to 2027: U.S. Market is Estimated at $119.8 Million, While China is Forecast to Grow at 23.4% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug Eluting Balloons (DEBs) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Drug Eluting Balloons (DEBs) Market to Reach $1.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Drug Eluting Balloons (DEBs) estimated at US$400.1 Million in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 24.1% over the period 2020-2027.

Peripheral DEBs, one of the segments analyzed in the report, is projected to record 25.3% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Coronary DEBs segment is readjusted to a revised 20.7% CAGR for the next 7-year period.

The U. S. Market is Estimated at $119.8 Million, While China is Forecast to Grow at 23.4% CAGR

The Drug Eluting Balloons (DEBs) market in the U. S. is estimated at US$119.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$312.4 Million by the year 2027 trailing a CAGR of 23.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.7% and 20.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.

The 174-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Acrostak Int. Distr. Sarl
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Cardionovum GmbH
  • Cook Medical, Inc.
  • Eurocor GmbH
  • Medtronic PLC
  • Spectranetics Corporation

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Drug Eluting Balloons (DEBs) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World 15-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Peripheral DEBs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Coronary DEBs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Cath Labs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

  • Market Facts & Figures
  • Drug Eluting Balloons (DEBs) Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product – Peripheral DEBs and Coronary DEBs – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • Historic Review for Drug Eluting Balloons (DEBs) by Product – Peripheral DEBs and Coronary DEBs Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
  • 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product – Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027
  • Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use – Cath Labs, Hospitals and Ambulatory Surgery Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
  • Historic Review for Drug Eluting Balloons (DEBs) by End-Use – Cath Labs, Hospitals and Ambulatory Surgery Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
  • 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use – Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/4czgpl

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900